WO2009010687A3 - Enzyme cible dans le traitement de l'acne - Google Patents

Enzyme cible dans le traitement de l'acne Download PDF

Info

Publication number
WO2009010687A3
WO2009010687A3 PCT/FR2008/051269 FR2008051269W WO2009010687A3 WO 2009010687 A3 WO2009010687 A3 WO 2009010687A3 FR 2008051269 W FR2008051269 W FR 2008051269W WO 2009010687 A3 WO2009010687 A3 WO 2009010687A3
Authority
WO
WIPO (PCT)
Prior art keywords
acne
treatment
target enzyme
enzyme
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR2008/051269
Other languages
English (en)
Other versions
WO2009010687A2 (fr
Inventor
Laurent Lamy
Michel Rivier
Gerard Feraille
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC
Priority to EP08826450A priority Critical patent/EP2167677A2/fr
Priority to CA2693153A priority patent/CA2693153A1/fr
Publication of WO2009010687A2 publication Critical patent/WO2009010687A2/fr
Publication of WO2009010687A3 publication Critical patent/WO2009010687A3/fr
Priority to US12/652,283 priority patent/US20100168231A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/20—Dermatological disorders
    • G01N2800/202—Dermatitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention a pour objet l'utilisation d'une enzyme (la DHRS9) comme outil de recherche dans l'acné. L'invention a également pour objet l'utilisation de cette enzyme pour l'identification d'un composé destiné au traitement de l'acné et/ou de tout désordre associé à une hyperséborrhée cutanée, ainsi qu'un procédé d'identification d'un tel composé.
PCT/FR2008/051269 2007-07-06 2008-07-07 Enzyme cible dans le traitement de l'acne Ceased WO2009010687A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP08826450A EP2167677A2 (fr) 2007-07-06 2008-07-07 Enzyme cible dans le traitement de l'acne
CA2693153A CA2693153A1 (fr) 2007-07-06 2008-07-07 Enzyme cible dans le traitement de l'acne
US12/652,283 US20100168231A1 (en) 2007-07-06 2010-01-05 Target enzyme for the treatment of acne

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0756309 2007-07-06
FR0756309A FR2918388B1 (fr) 2007-07-06 2007-07-06 Enzyme cible dans le traitement de l'acne.

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/652,283 Continuation US20100168231A1 (en) 2007-07-06 2010-01-05 Target enzyme for the treatment of acne

Publications (2)

Publication Number Publication Date
WO2009010687A2 WO2009010687A2 (fr) 2009-01-22
WO2009010687A3 true WO2009010687A3 (fr) 2009-05-22

Family

ID=39027085

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2008/051269 Ceased WO2009010687A2 (fr) 2007-07-06 2008-07-07 Enzyme cible dans le traitement de l'acne

Country Status (5)

Country Link
US (1) US20100168231A1 (fr)
EP (1) EP2167677A2 (fr)
CA (1) CA2693153A1 (fr)
FR (1) FR2918388B1 (fr)
WO (1) WO2009010687A2 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001017523A1 (fr) * 1999-09-10 2001-03-15 Applied Genetics Incorporated Dermatics Compositions et methodes pour modifier le taux de lipides cutanes
WO2002015920A2 (fr) * 2000-08-17 2002-02-28 University Of Sheffield Traitement des maladies d'hyperproliferation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001017523A1 (fr) * 1999-09-10 2001-03-15 Applied Genetics Incorporated Dermatics Compositions et methodes pour modifier le taux de lipides cutanes
WO2002015920A2 (fr) * 2000-08-17 2002-02-28 University Of Sheffield Traitement des maladies d'hyperproliferation

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
EVERTS H B ET AL.: "Immunolocalization of enzymes, binding proteins, and receptors sufficient for retinoic acid synthesis and signaling during the hair cycle", JOURNAL OF INVESTIGATIVE DERMATOLOGY, vol. 127, no. 7, 15 March 2007 (2007-03-15), UNITED STATES doi:10.1038/sj.jid.5700753, pages 1593 - 1604, XP009095931, ISSN: 0022-202X 1523-1747 *
HAYES A J ET AL.: "Toxicity of Australian essential oil Backhousia citriodora (Lemon myrtle). Part 1. Antimicrobial activity and in vitro cytotoxicity", FOOD AND CHEMICAL TOXICOLOGY, vol. 40, no. 4, April 2002 (2002-04-01), GB doi:10.1016/S0278-6915(01)00103-X, pages 535 - 543, XP009114788, ISSN: 0278-6915 *
NAPOLI J L.: "Interactions of retinoid binding proteins and enzymes in retinoid metabolism.", BIOCHIMICA ET BIOPHYSICA ACTA, vol. 1440, no. 2-3, 22 September 1999 (1999-09-22), NL doi:10.1016/S1388-1981(99)00117-1, pages 139 - 162, XP004277240, ISSN: 0006-3002 *
VIYOCH J ET AL.: "Evaluation of in vitro antimicrobial activity of Thai basil oils and their micro-emulsion formulas against Propionibacterium acnes", INTERNATIONAL JOURNAL OF COSMETIC SCIENCE, vol. 28, no. 2, April 2006 (2006-04-01), GB doi:10.1111/j.1467-2494.2006.00308.x, pages 125 - 133, XP009114789, ISSN: 0142-5463 *

Also Published As

Publication number Publication date
FR2918388A1 (fr) 2009-01-09
WO2009010687A2 (fr) 2009-01-22
FR2918388B1 (fr) 2009-10-23
US20100168231A1 (en) 2010-07-01
EP2167677A2 (fr) 2010-03-31
CA2693153A1 (fr) 2009-01-22

Similar Documents

Publication Publication Date Title
WO2007149621A3 (fr) Procédés et systèmes pour l'identification et l'authentification d'objets
WO2011044298A3 (fr) Systèmes et procédés pour établir une représentation environnementale
WO2007118219A3 (fr) Identification biométrique
WO2008073483A3 (fr) Procédés et systèmes liés à la réception d'information associée à des nutraceutiques
WO2008086282A3 (fr) Procédés et systèmes pour utiliser des informations électriques dans le cadre de la fabrication d'un dispositif sur une tranche afin d'accomplir une ou plusieurs fonctions liées à des défauts
IL185261A0 (en) Method, apparatus and computer program for azimuth determination e.g. for autonomous navigation applications
EP1903478A3 (fr) Procédés et systèmes pour définir, identifier et apprendre des caractéristiques géométriques
WO2010088517A8 (fr) Procédés et systèmes destinés à purifier, transférer et/ou manipuler des acides nucléiques
WO2009097979A3 (fr) Élément de sécurité
WO2010009000A3 (fr) Connecteurs rubans pour appareils de mesure
WO2007148300A3 (fr) Méthodes et systèmes de stockage de contenus obtenus par la technologie 'pousser'
HK1214830A1 (zh) 新型ntrk1融合分子及其应用
WO2009075554A3 (fr) Procédé et système permettant de fournir des informations sur les brevets
WO2008089397A3 (fr) Marqueurs du cancer adrb2
WO2009037473A3 (fr) Caractérisation de nucléobases
AP2011005659A0 (en) Method and system for item identification.
EP2023246A4 (fr) Système de traitement d'informations, procédé de traitement d'informations, et dispositif et programme utilisés pour le système de traitement d'informations et le procédé de traitement d'informations
EP2274598B8 (fr) Systèmes et procédés pour l'identification et l'analyse des gemmes
WO2011032142A3 (fr) Système et procédé pour reconnaissance pléomorphe, mise en correspondance et identification d'images et d'objets
IL223076A0 (en) Novel as160-like protein, test systems, methods and uses involving it for the identification of diabetes type 2 therapeutics
WO2009085196A8 (fr) Procédés et compositions pour corréler des marqueurs génétiques avec un risque de cancer de la prostate
WO2007076174A3 (fr) Procédés, systèmes et dispositif pour marqueurs multidomaines
WO2009120183A3 (fr) Système pour la détection d’un pathogène biologique et utilisation de celui-ci
WO2008043543A3 (fr) Balises d'acides nucleiques pour l'hybridation in situ en fluorescence et technologie a puces
WO2009014565A3 (fr) Procédés pour le diagnostic et le traitement des astrocytomes

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08826450

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2008826450

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2693153

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE